Use of time-kill methodology to assess antimicrobial combinations against metronidazole-susceptible and metronidazole-resistant strains of Helicobacter pylori
Open Access
- 1 December 1995
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 39 (12) , 2641-2644
- https://doi.org/10.1128/aac.39.12.2641
Abstract
Optimal therapy for Helicobacter pylori infection to date, consists of metronidazole, bismuth, and tetracycline. This combination, however, is less effective against metronidazole-resistant organisms. We used a time-kill kinetic methodology to assess the bactericidal effects of selected agents, alone and in combination, to a metronidazole-susceptible and a metronidazole-resistant strain of H. pylori. single, double, and triple agents showed increasing bactericidal activity. The combination of metronidazole, bismuth, and tetracycline showed maximal killing effect (no detectable regrowth) against the susceptible strain, but against the resistant strain this combination showed less killing. The time-kill methodology may therefore offer an in vitro approach to the initial selection of agents to be evaluated for the treatment of H. pylori infections.Keywords
This publication has 16 references indexed in Scilit:
- In vitro killing of penicillin-suseceptible, -intermediate, and -resistant strains of streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: A comparison of bactericidal and inhibitory activity with achievable CSF levelsDiagnostic Microbiology and Infectious Disease, 1995
- Antibacterial Treatment of Gastric Ulcers Associated withHelicobacter pyloriNew England Journal of Medicine, 1995
- Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phasesAntimicrobial Agents and Chemotherapy, 1995
- Evidence for the essential role of Helicobacter pylori in gastric ulcer disease.Gut, 1994
- Local gastric and serum amoxicillin concentrations after different oral application formsAntimicrobial Agents and Chemotherapy, 1993
- In vitro susceptibility of Helicobacter pylori to several antimicrobial combinationsAntimicrobial Agents and Chemotherapy, 1993
- Helicobacter pylori: Its Role in DiseaseClinical Infectious Diseases, 1992
- Experience with‘triple’ anti‐Helicobacter pylori eradication therapy: side effects and the importance of testing the pre‐treatment bacterial isolate for metronidazole resistanceAlimentary Pharmacology & Therapeutics, 1992
- Effect of Treatment of Helicobacter pylori Infection on the Long-term Recurrence of Gastric or Duodenal UlcerAnnals of Internal Medicine, 1992
- In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori)Antimicrobial Agents and Chemotherapy, 1987